The function of clusterin, a heterodimeric glycoprotein markedly induced in renal and other organ injuries, is unclear. Since renal injury is accompanied by alterations in cell attachment, it is possible that clusterin functions to promote cell-cell and cell-substratum interactions. In this study, a single cell suspension of renal epithelial (LLC-PK1) cells was treated with purified human clusterin, resulting in time-and dose-dependent cell aggregation. Electron microscopy of the cell aggregates demonstrated cell junction and lumen formation. To determine the effect of clusterin on cell adhesion, tissue culture plates were coated with clusterin, fibronectin, PBS, or albumin. Clusterin and fibronectin promoted cell adhesion to the same extent. The adhesion to clusterin was dose dependent and specific, as a monoclonal antibody against clusterin inhibited cell adhesion to clusterin but not fibronectin. Perterbations of the cytoskeleton may underlie the alterations in cell attachment which occur in renal injury. Induction of clusterin mRNA was seen after disruption of both microtubules and microfilaments and after inhibition of cell-substratum interactions. In conclusion, clusterin is a potent renal epithelial cell aggregation and adhesion molecule. We speculate that clusterin functions to promote cell-cell and cellsubstratum interactions which are perturbed in the setting of renal injury, thereby preserving the integrity of the renal epithelial barrier. clear. Since renal injury is accompanied by alterations in cell attachment, it is possible that clusterin functions to promote cell-cell and cell-substratum interactions. In this study, a single cell suspension of renal epithelial (LLC-PK1) cells was treated with purified human clusterin, resulting in timeand dose-dependent cell aggregation. Electron microscopy of the cell aggregates demonstrated cell junction and lumen formation. To determine the effect of clusterin on cell adhesion, tissue culture plates were coated with clusterin, fibronectin, PBS, or albumin. Clusterin and fibronectin promoted cell adhesion to the same extent. The adhesion to clusterin was dose dependent and specific, as a monoclonal antibody against clusterin inhibited cell adhesion to clusterin but not fibronectin. Perturbations of the cytoskeleton may underlie the alterations in cell attachment which occur in renal injury. Induction of clusterin mRNA was seen after disruption of both microtubules and microfilaments and after inhibition of cell-substratum interactions. In conclusion, clusterin is a potent renal epithelial cell aggregation and adhesion molecule. We speculate that clusterin functions to promote cell-cell and cell-substratum interactions which are perturbed in the setting of renal injury, thereby preserving the integrity of the renal epithelial barrier. (J. Clin. Invest. 1995Invest. . 96:2646Invest. -2653
Introduction
Clusterin, a glycoprotein first isolated from ram rete testes fluid, is named for its ability to elicit the clustering of a number of cell types (1, 2) . Species and tissue homologues of clusterin have been isolated and/or cloned by groups working in widely divergent areas (3) (4) (5) (6) (7) . This has resulted in multiple names for clusterin, including complement cytolysis inhibitor (CLI), (DAG), SP-40,40, gp80, apo J, NAl/NA2, and glycoprotein III (3) (4) (5) (6) (7) .
Clusterin is a heterodimer consisting of two 40-kD chains joined by a unique five-disulfide bond motif (8) . The protein precursor of clusterin is encoded on a single 2-kb mRNA which is transcribed from a single copy gene located on chromosome 8 (8p2l) (9, 10) . A signal peptide is present on the protein precursor. Clusterin has a long a-helix near the amino terminal, at least six N-linked glycosylation sites, several potential heparin-binding domains, three amphipathic helix domains, and a putative dinucleotide-binding domain (3, 6, 8, (11) (12) (13) .
Clusterin is found in numerous physiologic fluids and in most organs, with the highest levels in the testes, epididymis, liver, stomach, and brain ( 14, 15 ) . Additionally, developmental regulation of clusterin expression is seen. In the kidney, for example, clusterin is expressed in the ureteric bud but not in surrounding mesenchyme (16, 17) . As the mesenchyme is induced to form renal epithelium, clusterin is expressed and continues to be present in developing tubules. In the developing lung, clusterin is present in the bronchial tree and its expression follows a similar time course seen with branching morphogenesis (17) . No clusterin is seen in the mature lung. This temporal expression of clusterin during ontogeny at sites where critical cell interactions occur implies a role in organogenesis.
A unique and defining feature of clusterin is its induction in many organs, particularly the brain and kidney, at times of tissue injury. Despite its immediate and often prominent recruitment after injury, the role of clusterin remains elusive. Proposed functions for clusterin in this setting include apoptotic initiation, complement defense, lipid recycling, and membrane protection (3, 4, 7) .
We hypothesize that a function of clusterin in renal injury is to promote cell-cell and cell-substratum interactions. This hypothesis derives from the potent ability of clusterin to promote interactions in nonrenal cells and the typical disturbances in cell interactions that accompany renal injury. To begin to test this hypothesis, we examined the effects of clusterin on renal epithelial cell interactions. Since cell interactions are dependent on integrity of the cytoskeleton, and disruption of the cytoskeleton is an early feature of renal injury, we also examined the in vitro effects of cytoskeletal disruption on clusterin expression. Finally, we inhibited cell-substratum interactions to determine if the state of these interactions affects clusterin expression. 
Methods
Purification of clusterin. Clusterin was purified from fresh human sera by immunoaffinity chromatography using the mouse anti-human clusterin mAb G7 (gift of Brendan Murphy, Melbourne, Australia) (18) .
To each 25 ml of sera was added 65 Al of 0.2 M phenylmethylsulfonyl fluoride (Sigma Chemical Co., St. Louis, MO) in 30% ethanol and 3 grams of polyethylene glycol, 12% wt/vol (Sigma). After centrifugation, 5.75 grams polyethylene glycol, 23% wt/vol, was added to the supernatant and the resulting precipitate was dissolved in 10 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, filtered, and applied to the immunoaffinity column. The column was sequentially washed with: (a) 20 ml of 10 mM phosphate, 500 mM sodium chloride, 10 mM EDTA, pH 7.4; (b) 20 ml PBS (Sigma) containing 0.5% Triton X-100 (Research Organics, Cleveland, OH) to remove apo A-l and lipids coupled to circulating clusterin; and (c) 30 ml PBS. Clusterin was then eluted with 0.2 M glycine-hydrochloride, 0.5 M sodium chloride (pH 2.8) and immediately neutralized with 1 ml of 2 M Tris-HCl (pH 7.0). Further purification was performed by running the eluate through a protein A column (Sigma) to remove any contaminating immunoglobulin. The resulting sample was concentrated and purity documented by SDS-PAGE performed according to the method of Laemmli (19) . As expected, clusterin appeared as a 40-kD doublet under reduced conditions and an 80-kD band under unreduced conditions (data not shown). The concentration of clusterin was measured by the Coomassie blue dye method of Bradford using BSA (fraction V powder; Sigma) as a standard (20) .
Cell culture. Porcine renal epithelial cells (LLC-PKl ) were obtained from the American Type Culture Collection (Rockville, MD) at passage number 196. Cells were grown in DME (Sigma) at 37°C in 95% air and 5% carbon dioxide. The medium was supplemented with 5% FBS, L-glutamine (330 pg/ml), Hepes (5.9 mg/ml), penicillin (100 U/ml), and streptomycin (100 Aig/ml). All (21) . No aggregation was scored as "0" and a tightly packed aggregate of cells was scored as "4+". The continuum between these values was denoted "1+", "2+", or "3+".
To determine the requirements for calcium and magnesium, additional aggregation studies were performed in calcium-and magnesiumfree HBSS (Life Technologies, Grand Island, NY) containing 2.5 mM EDTA (Sigma). To determine whether active protein synthesis was required for clusterin-induced cell aggregation, LLC-PKl cells were incubated with 1-100 pg/ml cycloheximide (Sigma) for 30 min before and during the cell aggregation studies.
Adhesion assay. Each well of a 24-well polystyrene plate (Costar Corp.) was coated with 200 ttl of one of the following at 50 sg/ml: BSA, human fibronectin (Collaborative Biomedical Products, Bedford, MA), or human clusterin. PBS and BSA were used as negative controls, and the fibronectin as a positive control. The plate was incubated overnight in a 370C humidified incubator. The wells were then washed with PBS followed by incubation with 2 mg/ml BSA in PBS to block nonspecific binding sites. A cell suspension was prepared as described above, using serum-free basal medium Eagle's containing 1 mg/ml BSA instead of PBS. The flask of cells was radiolabeled the day before with 125 ,l 5"Cr (250-500 mCi/mg Cr; Amersham Corp., Arlington Heights, IL). The concentration of the cells was adjusted to 5-8 X 10" cells/ ml and a total of 500 pl of radiolabeled cell suspension was then added to each well. The plates were incubated at 370C for 30, 60, or 90 min.
Nonadherent cells were removed from each well and the individual wells were washed twice with PBS. Adherent cells were then solubilized by incubation with 1 M sodium hydroxide for 10 min. The washings (nonadherent cells) and solubilized (adherent) cells were counted separately in a gamma counter (Gamma 7000; Beckman Instruments Inc., Palo Alto, CA) and percent cell adhesion was calculated as adherent cells/(adherent cells + nonadherent cells) X 100.
A dose-response curve for clusterin-induced cell adhesion was performed using clusterin concentrations ranging from 1 to 100 1Lg/ml. The values for an albumin control were subtracted from the clusterin values to obtain the final percent cell adhesion. Additional adhesion assays were performed in the presence of 300 ,g/ml of the anticlusterin mAb G7 or purified mouse IgG-1 Kappa (Organon Teknika Corp., Durham, NC). These antibodies were mixed with the cell suspension before placement in the well.
Spreading of the adherent cells was evaluated by performing adhesion assays as described above. The cells were then fixed with 2% glutaraldehyde (Sigma), stained with hematoxylin (Zymed Labora- Electron microscopy. To determine whether clusterin promotes more permanent cell interactions, a single cell suspension of LLC-PKI cells was incubated for 18 h with 50 Mg/ml clusterin, resulting in the forma- RNA extraction and Northern blot hybridization. RNA was extracted from cells subjected to the conditions described above by the method of Chomczynski and Sacchi (22) . Clusterin mRNA was quantitated by Northern hybridization as described previously (23) . The cDNA probe was rat TRPM-2 (clusterin; gift of Martin Tenniswood, University of Ottawa, Ottawa, Ontario, Canada) (24) . For preparation of the cDNA probe, we used the method of random oligomer-primer labeling (Stratagene La Jolla, CA) with [32P]dCTP (6,000 Ci/mmol; NEN DuPont, Wilmington, DE). The specific activity of the probe was 1-2 X 109 cpm/pg DNA. Statistical analysis. Statistical significance was defined as P < 0.05 and the results were presented as mean±SEM. The significance of the differences was analyzed by the Student's t test of unpaired data by ANOVA, followed by the Bonferroni test for multiple group compari- (Fig. 1 a) , whereas in the presence of 50 jig/ml clusterin, a tight aggregate of cells was seen when examined at 60 min (Fig. 1 b) . Cell aggregation was seen at concentrations as low as 2.5 ptg/ml and the degree of aggregation increased with increasing clusterin concentrations, plateauing at 50 ptg/ml. Cells began to aggregate as early as 5 min after the addition of 50 pg/ml clusterin, with maximal aggregation seen at 45 min. Electron micrographs of the cell aggregates 18 h after the addition of clusterin demonstrated extensive desmosome formation (Fig. 2 A) . In many cases, intercellular lumen formation occurred (Fig. 2 B) . Thus, clusterin not only caused cells to aggregate but it also facilitated more permanent cell interactions.
There was no effect on the degree of cell aggregation when the assay was performed in the absence of either calcium or both calcium and magnesium. Pretreatment of cells with cycloheximide at a dose which inhibits protein synthesis did not affect clusterin-induced cell aggregation, providing evidence that prior protein synthesis is not necessary.
In contrast to LLC-PK1 cells, no aggregation was seen with L-929 cells and only minimal aggregation was seen with SK-OV-3 cells after clusterin addition under similar experimental conditions (data not shown).
Cell adhesion. Cell adhesion was significantly increased by clusterin in a time-and dose-dependent manner (Figs. 3 and  4) . The time course of clusterin-induced cell adhesion was similar to that of fibronectin (Fig. 3 ). An anticlusterin mAb G7 was used to test for the specificity of the clusterin-induced cell adhesion. The mAb inhibited cell adhesion to clusterin but not to albumin or fibronectin (Fig. 5 ). The control antibody had no effect on clusterin-induced cell adhesion. In addition to promoting cell adhesion, clusterin also enhanced cell spreading (Fig. 6 ). These studies provide evidence that clusterin is a potent cell adhesion and spreading molecule.
As with aggregation, however, the adhesive properties of clusterin were not seen with all cell types evaluated. SK-OV-3 cells exhibited marked adhesion with fibronectin and laminin, though no with agarose, an increase in clusterin ruRNA was observed (Fig. 9 ).
Discussion
The major findings of this paper are that clusterin is a renal epithelial cell aggregation and adhesion molecule, and that (1, 2) . In this study, aggregation of LLC-PK1 cells began at 5 min, reached a maximum by 45 min, and was dose dependent. The degree of aggregation was not dependent on the presence of extracellular calcium or magnesium and did not require new protein synthesis by the cells. The mechanism for this cell aggregation is unknown, though the failure of clusterin to aggre- gate all cell types argues against a nonspecific phenomenon. A unique clusterin receptor has not been identified, although glycoprotein 330 (gp 330), a receptor involved in the endocytosis of a number of ligands, can specifically bind clusterin and mediate its uptake into cells (25). Furthermore, the active site/ s of the clusterin molecule responsible for cell aggregation is/ are not known.
Increased cell aggregation occurs when interactions between substratum and anchorage-dependent cells are the weakest (26) . Given (16, 17) .
Increased expression of clusterin is seen in a wide array of disease states, pointing to a role in the tissue response to injury. These states include diseases of the central nervous system, kidney, and heart, as well as atherosclerosis and cancer (5, 7, (31) (32) (33) (34) (35) (36) (37) (38) . Proposed functions for clusterin in the setting of tissue injury include apoptotic initiation, complement defense, lipid recycling, membrane protection, and maintenance of cell-cell or cell-substratum contacts (3, 4, 7) . Definitive evidence for any of these proposed functions is scant, and the possibility exists that more than one, or an as yet undefined function, may be relevant.
We propose that clusterin is induced at times of tissue injury to promote cell-cell and cell-substratum interactions which are perturbed in these settings. This hypothesis is supported by both the ability of clusterin to promote cell interactions and the typical disturbances in cell interactions that accompany states associated with clusterin induction. This hypothesis is particularly pertinent to renal injury. Abnormalities in cell interactions that follow renal injury lead to cell rounding, retraction, and detachment; decreased binding of cells to matrix components; and aberrant cell-cell attachments (39) (40) (41) (42) (43) (44) (45) .
The cytoskeleton plays a key role in the maintenance of intercellular junctions and the attachment of cells to their substratum. Disruption of the cytoskeleton is an early finding in renal injury, leading to alterations in numerous cellular functions including the loss of cell contacts (39) (40) (41) 43) . The observed increase in clusterin mRNA after disruption of microtubules or microfilaments provides a link between changes in the cytoskeleton, renal injury, and clusterin induction.
Even mild injury can lead to profound nephron dysfunction mediated in part through alterations in cell attachment, a finding which is supported by the presence of viable epithelial cells in the urine after acute renal failure (46) . Detachment of tubular epithelial cells from the substratum leads to denuded epithelium and a consequent back leak of filtrate. Induction of clusterin under these conditions, with its subsequent enhancement of cell interactions, could be a beneficial response. Maintenance of cell-cell contacts by clusterin may be important in exchange of critical nutrients or other factors between cells, perhaps across gap junctions, and maintenance of cell-substratum contacts could prevent or lessen cell sloughing. In addition, maintenance of cell proximity would allow the normal junctional contacts to become reestablished once the injury passes. Many clinical conditions characterized by alterations in cell attachment, namely renal cystic disease and apoptosis, are associated with clusterin induction, further supporting our hypothesis ( 16, 36, (47) (48) (49) .
In conclusion, clusterin induces renal epithelial cell aggregation and adhesion. Disruption of the cytoskeleton and loss of cell-substratum interactions, both early changes after renal injury, lead to induction of clusterin mRNA. These findings, combined with the induction of clusterin in a wide variety of injuries or states of abnormal cell attachment, suggest that clusterin functions to maintain cell interactions in settings such as renal injury where normal interactions are perturbed.
